NFL Biosciences (FRA:82F) Marketable Securities: €0.20 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:82F NFL Biosciences SA FRA:82F
30 GF Score
Price €0.76
! 1 Warning Sign
View Full Analysis

What is NFL Biosciences Marketable Securities?

NFL Biosciences FRA:82F +0.40% 30 Marketable Securities is €0.20 Mil as of Dec. 2025. GuruFocus rates FRA:82F with a GF Score™ of 30/100. The stock has 1 warning sign investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. NFL Biosciences's Marketable Securities for the quarter that ended in Dec. 2025 was €0.20 Mil.

NFL Biosciences's annual Marketable Securities increased from Dec. 2023 (€0.19 Mil) to Dec. 2024 (€0.20 Mil) but then stayed the same from Dec. 2024 (€0.20 Mil) to Dec. 2025 (€0.20 Mil).

NFL Biosciences  (FRA:82F) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

NFL Biosciences Marketable Securities Related Terms

NFL Biosciences Marketable Securities Historical Data

* Premium members only.

The historical data trend for NFL Biosciences's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NFL Biosciences Marketable Securities Chart

NFL Biosciences Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial 0.17 0.16 0.19 0.20 0.20

NFL Biosciences Semi-Annual Data
Dec18 Dec19 Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.19 0.20 0.20 0.20 0.20
FRA:82F
30GF Score
NFL Biosciences SA FRA:82F
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

NFL Biosciences Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of €0.20 Mil mean?
NFL Biosciences (FRA:82F) has a Marketable Securities of €0.20 Mil as of Dec. 2025. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on NFL Biosciences and its competitors.
Is NFL Biosciences' Marketable Securities too high?
NFL Biosciences' current Marketable Securities is €0.20 Mil. Overall, NFL Biosciences has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does NFL Biosciences' Marketable Securities compare to VRTX and REGN?
NFL Biosciences' Marketable Securities of €0.20 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Biotechnology company?
A good Marketable Securities depends on the Biotechnology industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on NFL Biosciences and its competitors. NFL Biosciences's current Marketable Securities is €0.20 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NFL Biosciences stock overvalued right now?
NFL Biosciences (FRA:82F) has a current Marketable Securities of €0.20 Mil. The current Marketable Securities is €0.20 Mil. NFL Biosciences' overall GF Score™ is 30/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For NFL Biosciences (FRA:82F), the current Marketable Securities is €0.20 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

NFL Biosciences Business Description

Other Exchanges ALNFL:France
Address 199 rue Helene Boucher, Castelnau-le-Lez, FRA, 34170
NFL Biosciences SA specializes in the research and development of medicines to combat tobacco addiction that use botanical and pharmaceutical agents. NFL-101 is company's core product, targeting smoking addiction. It is a clinically developed, botanical drug that contains an insignificant amount of nicotine and is composed of well characterized, natural tobacco leaf proteins.
30GF Score

Get the complete analysis for FRA:82F

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.76
Price